Orca Biosystems, Inc.
Clinical trials sponsored by Orca Biosystems, Inc., explained in plain language.
-
New stem cell therapy aims to tame transplant complications in blood cancer patients
Disease control OngoingThis study tests a new treatment called Orca-T for people with advanced blood cancers like leukemia. Orca-T is a special stem cell transplant designed to reduce serious side effects like graft-versus-host disease. The trial compares Orca-T to standard stem cell transplants in 187…
Phase: PHASE3 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Last-Chance cell therapy for blood cancer patients when standard product fails
Disease control TEMPORARILY_NOT_AVAILABLEThis program gives patients with blood cancers like leukemia or myelodysplastic syndrome access to Orca-T, a cell therapy, when the commercial version made for them doesn't meet quality standards. The goal is to provide treatment when no other option is available. Participants ar…
Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC